Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Trends in Cancer|March 4, 2026
FGFR rearrangements: oncogenic drivers and therapeutic targetsJulia Yemelyanenko, Jos Jonkers, Daniel ZinggOncogene|April 6, 2004
Degradation of PKB/Akt protein by inhibition of the VEGF receptor/mTOR pathway in endothelial cellsOliver Riesterer, Daniel Zingg, Jörg Hummerjohann, et al.Expert Review of Pharmacoeconomics & Outcomes Research|July 25, 2017
Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT)Florian Wagenlehner, Björn Wullt, Stefania Ballarini, et al.Cancer Research|August 4, 2004
Differential activation of the phosphatidylinositol 3'-kinase/Akt survival pathway by ionizing radiation in tumor and primary endothelial cellsDaniel Zingg, Oliver Riesterer, Doriano Fabbro, et al.Journal of Bacteriology|January 18, 2011
Sulfate-driven elemental sparing is regulated at the transcriptional and posttranscriptional levels in a filamentous cyanobacteriumAndrian Gutu, Richard M Alvey, Sami Bashour, et al.International Journal of Radiation Oncology, Biology, Physics|January 31, 2004
Novel radiosensitizers for locally advanced epithelial tumors: inhibition of the PI3K/Akt survival pathway in tumor cells and in tumor-associated endothelial cells as a novel treatment strategy?Oliver Riesterer, Angela Tenzer, Daniel Zingg, et al.Science Progress|December 17, 2025
Classification of capillary damage in patients with type 2 diabetes mellitus: Clinical parameters obtained through capillaroscopy-A cross-sectional studyLuis Fernando Flota-Cervera, Francisco José González-García, Abdel Kerim Raffoul-Orozco, et al.Immunobiology|December 19, 2007
Responsiveness of fibrocytes to toll-like receptor danger signalsCarole Balmelli, Marco P Alves, Esther Steiner, et al.Cell Reports|July 27, 2017
The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor ImmunotherapyDaniel Zingg, Natalia Arenas-Ramirez, Dilara Sahin, et al.International Angiology : a Journal of the International Union of Angiology|May 23, 2025
Clinical evidence of venoactive drugs in diabetic microvascular complications: a scoping reviewGiacomo Gastaldi, Daniel Zingg, Alessandra Calabrese, et al.Pageof 3